RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Anne Coleman to Ocular Hypertension

This is a "connection" page, showing publications Anne Coleman has written about Ocular Hypertension.
Connection Strength

0.935
  1. Coleman AL, Singh K, Wilson R, Cioffi GA, Friedman DS, Weinreb RN. Applying an evidence-based approach to the management of patients with ocular hypertension: evaluating and synthesizing published evidence. Am J Ophthalmol. 2004 Sep; 138(3 Suppl):S3-10.
    View in: PubMed
    Score: 0.257
  2. Coleman AL, Caprioli J. The logic behind target intraocular pressure. Am J Ophthalmol. 2009 Mar; 147(3):379-80.
    View in: PubMed
    Score: 0.088
  3. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008 Nov; 53 Suppl1:S3-10.
    View in: PubMed
    Score: 0.086
  4. Coleman AL, Gordon MO, Beiser JA, Kass MA. Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004 Oct; 138(4):684-5.
    View in: PubMed
    Score: 0.065
  5. Weinreb RN, Friedman DS, Fechtner RD, Cioffi GA, Coleman AL, Girkin CA, Liebmann JM, Singh K, Wilson MR, Wilson R, Kannel WB. Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol. 2004 Sep; 138(3):458-67.
    View in: PubMed
    Score: 0.064
  6. Zangwill LM, Weinreb RN, Berry CC, Smith AR, Dirkes KA, Liebmann JM, Brandt JD, Trick G, Cioffi GA, Coleman AL, Piltz-Seymour JR, Gordon MO, Kass MA. The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors. Am J Ophthalmol. 2004 Feb; 137(2):219-27.
    View in: PubMed
    Score: 0.062
  7. Zangwill LM, Weinreb RN, Berry CC, Smith AR, Dirkes KA, Coleman AL, Piltz-Seymour JR, Liebmann JM, Cioffi GA, Trick G, Brandt JD, Gordon MO, Kass MA. Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Arch Ophthalmol. 2004 Jan; 122(1):22-8.
    View in: PubMed
    Score: 0.061
  8. Coleman AL, Lerner F, Bernstein P, Whitcup SM. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Ophthalmology. 2003 Dec; 110(12):2362-8.
    View in: PubMed
    Score: 0.061
  9. Tseng VL, Coleman AL, Chang MY, Caprioli J. Aqueous shunts for glaucoma. Cochrane Database Syst Rev. 2017 07 28; 7:CD004918.
    View in: PubMed
    Score: 0.039
  10. Zangwill LM, Jain S, Dirkes K, He F, Medeiros FA, Trick GL, Brandt JD, Cioffi GA, Coleman AL, Liebmann JM, Piltz-Seymour JR, Gordon MO, Kass MA, Weinreb RN. The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Am J Ophthalmol. 2013 Jun; 155(6):971-82.
    View in: PubMed
    Score: 0.029
  11. Nilforushan N, Nassiri N, Moghimi S, Law SK, Giaconi J, Coleman AL, Caprioli J, Nouri-Mahdavi K. Structure-function relationships between spectral-domain OCT and standard achromatic perimetry. Invest Ophthalmol Vis Sci. 2012 May 09; 53(6):2740-8.
    View in: PubMed
    Score: 0.027
  12. Weinreb RN, Zangwill LM, Jain S, Becerra LM, Dirkes K, Piltz-Seymour JR, Cioffi GA, Trick GL, Coleman AL, Brandt JD, Liebmann JM, Gordon MO, Kass MA. Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study. Ophthalmology. 2010 Sep; 117(9):1674-83.
    View in: PubMed
    Score: 0.024
  13. Griffin BA, Elliott MN, Coleman AL, Cheng EM. Incorporating mortality risk into estimates of 5-year glaucoma risk. Am J Ophthalmol. 2009 Dec; 148(6):925-31.e7.
    View in: PubMed
    Score: 0.023
  14. Lee PP, Walt JG, Doyle JJ, Kotak SV, Evans SJ, Budenz DL, Chen PP, Coleman AL, Feldman RM, Jampel HD, Katz LJ, Mills RP, Myers JS, Noecker RJ, Piltz-Seymour JR, Ritch RR, Schacknow PN, Serle JB, Trick GL. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006 Jan; 124(1):12-9.
    View in: PubMed
    Score: 0.018
  15. Zangwill LM, Weinreb RN, Beiser JA, Berry CC, Cioffi GA, Coleman AL, Trick G, Liebmann JM, Brandt JD, Piltz-Seymour JR, Dirkes KA, Vega S, Kass MA, Gordon MO. Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2005 Sep; 123(9):1188-97.
    View in: PubMed
    Score: 0.017
  16. Wilson MR, Coleman AL, Yu F, Fong Sasaki I, Bing EG, Kim MH. Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology. 2002 May; 109(5):1018-22.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support